The device focuses on examining sonoporation-based drug delivery that involves ultrasound-based treatment with microbubbles.

(MENAFN- GetNews) The Key Neuromodulation companies in the market include - Medtronic, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, NeuroSigma ...

The global Brain Pacemaker Market represents a rapidly expanding segment of the medical device industry, valued at USD 3.66 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The upcoming report from Abbott (ABT) is expected to reveal quarterly earnings of $1.25 per share, indicating an increase of 9.7% compared to the year-ago period. Analysts forecast revenues of $11.07 ...

Progress of BSX’s Competitors in the Neuromodulation Field In the first quarter of 2025, Abbott ’s ABT Neuromodulation segment demonstrated strategic progress through innovation and clinical ...

CVS Health (CVS - Free Report) has an Earnings ESP of +2.06% and a Zacks Rank #2 at present. The company is slated to release second-quarter 2025 results on July 31. You can see the complete list of ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Johnson & Johnson'sJNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular ...